Mamonta, Mejolyn C.
HRN: 26-05-43 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CEFTRIAXONE 1G (VIAL)
05/28/2025
06/03/2025
IV
2g
OD
Appendicitis
Checking Initial Appropriateness
05/28/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/28/2025
06/04/2025
IV
500mg
Q8h
ACUTE APPENDICITIS
Checking Initial Appropriateness